Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia
Loading...
Identifiers
Publication date
Authors
Freites Martínez, Azael David
Apalla, Zoe
Shapiro, Jerry
Iorizzo, Matilde
Rudnicka, Lidia
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
Persistent chemotherapy-induced alopecia (pCIA) is a distressing side effect of antineoplastic agents, imposing significant psychological burdens on cancer survivors. Despite its impact, there are no standardized guidelines for diagnosis, prevention or management. To establish consensus-based definitions, diagnostic criteria, grading systems and management recommendations for pCIA.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Freites‐Martinez, A., Apalla, Z., Shapiro, J., Iorizzo, M., Rudnicka, L., Lo Sicco, K., Nikolaou, V., Pirmez, R., Takwale, A., Fattore, D., Dulmage, B., Piraccini, B. M., Vano‐Galvan, S., Lacouture, M., Sibaud, V., & Starace, M. V. R. (2025). Expert consensus for prevention, diagnosis and management of persistent chemotherapy‐induced alopecia. Journal of the European Academy of Dermatology and Venereology, 39(12), 2039-2046. https://doi.org/10.1111/jdv.70021